Close
  Indian J Med Microbiol
 

Figure 5: (a) A photomicrograph of a section of the colon of the control group showing weak immunoreactivity in the mucosa. (b) A photomicrograph of a section of the colon of the colitis subgroup (IIa) showing strong immunoreactivity in the mucosa. (c) A photomicrograph of a section of the colon of the recovery subgroup (IIb) showing strong immunoreactivity in the upper third of the mucosa. (d) A photomicrograph of a section of the colon of the sulfasalazine-treated subgroup (IIc) showing mild immunoreactivity in the cells lining the crypts, and the surface epithelium. (e) A photomicrograph of a section of the colon of the royal jelly-treated subgroup (IId) showing weak immunoreactivity in the mucosa. Inducible nitric oxide synthase, (a– e) ×40.

Figure 5: (a) A photomicrograph of a section of the colon of the control group showing weak immunoreactivity in the mucosa. (b) A photomicrograph of a section of the colon of the colitis subgroup (IIa) showing strong immunoreactivity in the mucosa. (c) A photomicrograph of a section of the colon of the recovery subgroup (IIb) showing strong immunoreactivity in the upper third of the mucosa. (d) A photomicrograph of a section of the colon of the sulfasalazine-treated subgroup (IIc) showing mild immunoreactivity in the cells lining the crypts, and the surface epithelium. (e) A photomicrograph of a section of the colon of the royal jelly-treated subgroup (IId) showing weak immunoreactivity in the mucosa. Inducible nitric oxide synthase, (a– e) ×40.